Peter Scully

2.3k total citations · 3 hit papers
8 papers, 2.0k citations indexed

About

Peter Scully is a scholar working on Oncology, Ophthalmology and Genetics. According to data from OpenAlex, Peter Scully has authored 8 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Ophthalmology and 2 papers in Genetics. Recurrent topics in Peter Scully's work include Cancer-related Molecular Pathways (5 papers), Ocular Oncology and Treatments (5 papers) and interferon and immune responses (2 papers). Peter Scully is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Ocular Oncology and Treatments (5 papers) and interferon and immune responses (2 papers). Peter Scully collaborates with scholars based in United States and Belarus. Peter Scully's co-authors include Wen‐Hwa Lee, Jin‐Yuh Shew, Phang‐Lang Chen, Robert Bookstein, Jean Y. J. Wang, Eva Y.-H.P. Lee, Jin-Yuh Shew, Martin Haas, J Cheng and Lee Wh and has published in prestigious journals such as Science, Cell and Blood.

In The Last Decade

Peter Scully

8 papers receiving 2.0k citations

Hit Papers

Phosphorylation of the retinoblastoma gene product is mod... 1988 2026 2000 2013 1989 1990 1988 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Scully United States 7 1.4k 1.1k 587 443 266 8 2.0k
Frank Hong United States 13 1.4k 1.0× 1.2k 1.1× 880 1.5× 505 1.1× 364 1.4× 19 2.5k
W. F. Benedict United States 9 828 0.6× 998 0.9× 417 0.7× 416 0.9× 443 1.7× 11 1.9k
Barbara Faha United States 15 1.6k 1.2× 1.7k 1.5× 212 0.4× 637 1.4× 335 1.3× 19 2.5k
Joyce M. Rapaport United States 12 1.8k 1.3× 2.0k 1.7× 1.4k 2.4× 729 1.6× 596 2.2× 13 3.6k
Nicolas Janin France 19 620 0.5× 818 0.7× 116 0.2× 358 0.8× 314 1.2× 40 1.5k
M Wada United States 14 904 0.7× 882 0.8× 127 0.2× 235 0.5× 364 1.4× 19 1.6k
Huei-Jen Su Huang United States 6 555 0.4× 631 0.6× 190 0.3× 252 0.6× 159 0.6× 7 1.2k
Rosalyn Slater Netherlands 28 478 0.4× 1.4k 1.3× 151 0.3× 493 1.1× 392 1.5× 69 2.4k
Dennis C. Lynch United States 16 597 0.4× 827 0.7× 214 0.4× 331 0.7× 93 0.3× 22 1.7k
Gloria Balaban United States 19 630 0.5× 1.0k 0.9× 107 0.2× 332 0.7× 449 1.7× 23 1.7k

Countries citing papers authored by Peter Scully

Since Specialization
Citations

This map shows the geographic impact of Peter Scully's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Scully with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Scully more than expected).

Fields of papers citing papers by Peter Scully

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Scully. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Scully. The network helps show where Peter Scully may publish in the future.

Co-authorship network of co-authors of Peter Scully

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Scully. A scholar is included among the top collaborators of Peter Scully based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Scully. Peter Scully is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lapotko, Dmitri O., Ekaterina Y. Lukianova‐Hleb, С. А. Жданок, et al.. (2007). LANTCET: laser nanotechnology for screening and treating tumors ex vivo and in vivo. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 6735. 673516–673516. 2 indexed citations
2.
Cheng, J, et al.. (1990). Homozygous deletion of the retinoblastoma gene in an acute lymphoblastic leukemia (T) cell line. Blood. 75(3). 730–735. 7 indexed citations
3.
Bookstein, Robert, Jin‐Yuh Shew, Phang‐Lang Chen, Peter Scully, & Wen‐Hwa Lee. (1990). Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Gene. Science. 247(4943). 712–715. 523 indexed citations breakdown →
4.
Cheng, J, et al.. (1990). Homozygous deletion of the retinoblastoma gene in an acute lymphoblastic leukemia (T) cell line. Blood. 75(3). 730–735. 61 indexed citations
5.
Chen, Phang‐Lang, Peter Scully, Jin‐Yuh Shew, Jean Y. J. Wang, & Wen‐Hwa Lee. (1989). Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell. 58(6). 1193–1198. 852 indexed citations breakdown →
6.
Lee, Eva Y.-H.P., et al.. (1988). Inactivation of the Retinoblastoma Susceptibility Gene in Human Breast Cancers. Science. 241(4862). 218–221. 515 indexed citations breakdown →
7.
Scully, Peter, et al.. (1988). AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens.. PubMed. 130(2). 244–51. 38 indexed citations
8.
Scully, Peter, et al.. (1982). Argon laser use in papillomas of the larynx. The Laryngoscope. 92(10). 1164–1167. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026